Xiaoyan Li
发表
Zhen Liu,
Hao Wu,
Bruce G. Haffty,
2014,
Oncotarget.
Xia Ding,
Xiaoyan Li,
Qifeng Yang,
2014,
Cellular Physiology and Biochemistry.
Xiaoyan Li,
Qifeng Yang,
Xiaoli Kong,
2019,
Oncology letters.
Xiaoyan Li,
Qifeng Yang,
Xiaoli Kong,
2020,
Clinical breast cancer.
Xiaoyan Li,
Qifeng Yang,
Yi Duan,
2020,
Oncology letters.
Xiaoyan Li,
Qifeng Yang,
Yifei Wang,
2019
.
Xiaoyan Li,
Qifeng Yang,
Ning Zhang,
2019,
Oncogene.
Zhongqing Chen,
F. Tang,
Xiaoyan Li,
2020,
Cancer cell international.
Xiaoyan Li,
Qifeng Yang,
Ning Zhang,
2021,
Disease markers.
Xiaoyan Li,
Gang Wu,
Guoqiang Zhao,
2016,
Molecular medicine reports.
Xiaolong Wang,
Ning Zhang,
Hui-Yun Wang,
2013,
The Journal of Biological Chemistry.
B. Kong,
Xiaoyan Li,
Qifeng Yang,
2012,
Oncology reports.
Xiaolong Wang,
Hui-Yun Wang,
G. Hu,
2013
.
X. Chen,
Xiaoyan Li,
Qifeng Yang,
2012,
PloS one.
F. Liang,
Ning Zhang,
Xiaoyan Li,
2011,
BMC Medical Genetics.
Xiaoyan Li,
Wenyu Wang,
T. Gao,
2018,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
Xiaoyan Li,
Yang Yang,
Yunyan Zhou,
2015,
Oncology letters.
Xia Ding,
Xiaoyan Li,
Qifeng Yang,
2017,
Cellular Physiology and Biochemistry.
Xiaoyan Li,
Xiuping Liu,
Q. Zou,
2018,
Cancer science.
Chen Huang,
Xiaoyan Li,
Liang Shi,
2021,
Cell Death & Disease.
Jin Zhao,
Liping Zhao,
Changjing Wu,
2021,
Journal of translational medicine.
Xiaoyan Li,
Qifeng Yang,
Q. Huo,
2016,
Oncology letters.
K. Young,
Juan Liu,
Cen Zhang,
2014,
Nature Communications.
Duan Ma,
Xiaoyan Li,
Q. Zou,
2020,
Oncogene.
Xiaoyan Li,
Q. Zou,
Chengyu Chu,
2021,
Annals of translational medicine.
J. Lehár,
Manway Liu,
R. Schlegel,
2014,
Cancer cell.
W. Sellers,
Nanxin Li,
D. Ruddy,
2017,
eLife.
Haiyang Guo,
C. Shao,
Xiaoyan Li,
2011,
Cancer science.
Wenwei Hu,
Xiaoyan Li,
Qifeng Yang,
2011,
PloS one.
H. Huynh,
Angela Tam,
J. Monahan,
2015,
Cancer discovery.
Xiaoyan Li,
Qifeng Yang,
B. Haffty,
2014,
Tumor Biology.
Xiaoyan Li,
Qifeng Yang,
Xiangnan Kong,
2013,
Cancer science.
Xiaoyan Li,
Qifeng Yang,
Xiangnan Kong,
2013,
PloS one.
53BP1 functions as a tumor suppressor in breast cancer via the inhibition of NF-κB through miR-146a.
C. Shao,
Xiaoyan Li,
Qifeng Yang,
2012,
Carcinogenesis.
LncRNA LINP1 confers tamoxifen resistance and negatively regulated by ER signaling in breast cancer.
Xiaoyan Li,
Qifeng Yang,
Ning Zhang,
2020,
Cellular signalling.
Xiaoyan Li,
Qifeng Yang,
Ning Zhang,
2020,
Molecular Cancer.
Xia Ding,
Qifeng Yang,
Xia Ding,
2015,
Cancer science.
Xiaoyan Li,
Qifeng Yang,
Ning Zhang,
2019,
Molecular therapy. Nucleic acids.
Xiaoyan Li,
Xiuping Liu,
Q. Zou,
2019,
International journal of clinical and experimental pathology.
Xiaoyan Li,
Qifeng Yang,
B. Haffty,
2013,
Biochemical and biophysical research communications.
Xiaoyan Li,
Huantao Liu,
Lubing Tang,
2018,
Experimental and therapeutic medicine.
Low-dose radiation-induced epithelial-mesenchymal transition through NF-κB in cervical cancer cells.
B. Kong,
Xiaoyan Li,
Qifeng Yang,
2013,
International journal of oncology.
Xiaoyan Li,
Qifeng Yang,
Xiangnan Kong,
2015,
International journal of oncology.
Xiaoyan Li,
Qifeng Yang,
Yiran Liang,
2021,
Frontiers in surgery.
Xiaoyan Li,
Q. Zou,
Jing He,
2019,
International journal of genomics.
Xiaoyan Li,
Qifeng Yang,
Xin Zhang,
2014,
Tumor Biology.
Xiaoyan Li,
Qifeng Yang,
Xiaoli Kong,
2017,
Oncotarget.
Ning Zhang,
Xiaoyan Li,
H. Zhuang,
2011
.
Xiaoyan Li,
Qifeng Yang,
Yiran Liang,
2021,
BMC Surgery.
B. Kong,
Xiaoyan Li,
Qifeng Yang,
2018,
Oncology letters.
Xiaoyan Li,
Qifeng Yang,
Ning Zhang,
2020,
Molecular Cancer.
Xiaoyan Li,
Qifeng Yang,
Wenjing Zhao,
2019,
Surgical oncology.
Xia Ding,
Xiaoyan Li,
Qifeng Yang,
2014,
PloS one.
Xiaoyan Li,
Qifeng Yang,
Ning Zhang,
2019,
Cancer medicine.
J. Lehár,
Anupama Reddy,
P. Finan,
2012,
PloS one.
Xiaoyan Li,
Liguang Yang,
Jianguo Huang,
2015,
The Tohoku journal of experimental medicine.
Xiaoyan Li,
Wei Wei,
Lili Yu,
2016,
The Journal of toxicological sciences.
Xiaoyan Li,
Qifeng Yang,
M. Moran,
2011,
Biochemical and biophysical research communications.
R. Schlegel,
M. Peters,
M. Pinzon-Ortiz,
2013
.
Xiaoyan Li,
Chuang-xin Lu,
Yunyan Zhou,
2011
.
Retraction Note to: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
Xiaoyan Li,
Qifeng Yang,
Ning Zhang,
2022,
Molecular cancer.
Xia Ding,
Xiaoyan Li,
Qifeng Yang,
2017,
Scientific Reports.
Xiaoyan Li,
Xiuping Liu,
Q. Zou,
2021,
Oncogene.
Xiaoyan Li,
Qifeng Yang,
Xiangnan Kong,
2012
.
Xiaoyan Li,
Yunyan Zhou,
Wenyu Wang,
2016,
Oncology letters.
Xiaoyan Li,
Qifeng Yang,
Xiangnan Kong,
2014,
Cellular Physiology and Biochemistry.
Xiaoyan Li,
Qifeng Yang,
B. Haffty,
2012,
Cancer science.
Xiaoyan Li,
T. Gao,
Lin-wei Li,
2017,
American journal of translational research.
Xiaoyan Li,
Qifeng Yang,
Xiaoli Kong,
2019,
The breast journal.
Ning Zhang,
B. Kong,
Xiaoyan Liu,
2015,
Oncology reports.
Mitsutoshi Nakamura,
H. Nakase,
S. Hirota,
2012
.
Xiaoyan Li,
Qifeng Yang,
Ning Zhang,
2019,
Oncogene.
Xiaoyan Li,
Qifeng Yang,
Xiangnan Kong,
2015,
International journal of oncology.
Xiaoyan Li,
T. Gao,
Lin-wei Li,
2017,
American journal of translational research.
Xiaoyan Li,
Qifeng Yang,
Ning Zhang,
2019,
Molecular therapy. Nucleic acids.
Xiaoyan Li,
Z. Yingjie,
Jian Zhang,
2014,
Current drug targets.